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Abstract. 
 
We have established a cell culture system 
that reproduces morphogenic processes in the develop-
ing mammary gland. EpH4 mouse mammary epithelial 
cells cultured in matrigel form branched tubules in the 
presence of hepatocyte growth factor/scatter factor 
(HGF/SF), the ligand of the c-met tyrosine kinase re-
ceptor. In contrast, alveolar structures are formed in 
the presence of neuregulin, a ligand of c-erbB tyrosine 
kinase receptors. These distinct morphogenic responses 
can also be observed with selected human mammary 
carcinoma tissue in explant culture. HGF/SF-induced 
branching was abrogated by the PI3 kinase inhibitors 
wortmannin and LY294002. In contrast, neuregulin-
induced alveolar morphogenesis was inhibited by the 
MAPK kinase inhibitor PD98059. The c-met–mediated 
response could also be evoked by transfection of a
c-met specific substrate, Gab1, which can activate the 
PI3 kinase pathway. An activated hybrid receptor that 
contained the intracellular domain of c-erbB2 receptor 
suffices to induce alveolar morphogenesis, and was
observed in the presence of tyrosine residues Y1028, 
Y1144, Y1201, and Y1226/27 in the substrate-binding 
domain of c-erbB2. Our data demonstrate that c-met 
and c-erbB2 signaling elicit distinct morphogenic pro-
grams in mammary epithelial cells: formation of 
branched tubules relies on a pathway involving PI3 ki-
nase, whereas alveolar morphogenesis requires MAPK 
kinase.
Key words: development of mammary gland • hepa-
tocyte growth factor • neuregulin • PI3 kinase • MAPK 
kinase
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 and morphogenesis of epithelia are essen-
tial processes in the development of many organs,
which are driven not only by an intrinsic genetic
program but also by signals provided by neighboring cells
and tissues. Accordingly, studies performed in organ cul-
ture and transplantation experiments have demonstrated
that growth and morphogenesis of epithelia from the sali-
vary gland, kidney, lung, or the mammary gland are con-
trolled by mesenchymal–epithelial interactions (Grob-
stein, 1953; Spooner and Wessells, 1970; Saxen 1987;
Sakakura, 1991). The identification of molecules that pro-
vide the essential signals exchanged in mesenchymal–epi-
thelial interactions is an area of active research. Recent ev-
idence suggests that morphogenic programs of epithelia
can be triggered by mesenchymal factors that signal via ty-
rosine kinase receptors (Montesano et al., 1991
 
a
 
,
 
b
 
; Schu-
chardt et al., 1994; Sutherland et al., 1996; for review see
Birchmeier and Birchmeier, 1993). This is also supported
by genetic experiments in mice that illustrate the impor-
tance of mesenchymal ligands of epithelial tyrosine ki-
nases during development of the kidney, lung, and liver
(Peters et al., 1994; Schuchardt et al., 1994; Bladt et al.,
1995; Schmidt et al., 1995; Uehara et al., 1995; Moore
 
 
 
et
al., 1996; Pichel et al., 1996; Sanchez et al., 1996). Similarly,
branching of trachea in 
 
Drosophila 
 
is controlled by a fi-
broblast growth factor-like molecule produced in sur-
rounding mesenchymal cells (Sutherland et al., 1996).
We have previously identified two mesenchymal ligands
of epithelial receptor tyrosine kinases, hepatocyte growth
factor/scatter factor (HGF/SF)
 
1
 
 and neuregulin, to be im-
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factor; NGF, nerve growth factor. 
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portant for development of the mammary gland (Yang et
al., 1995). In whole organ cultures of mouse mammary
glands, HGF/SF promotes branching of ductal trees and
inhibits terminal differentiation, as assessed by the expres-
sion of milk proteins. In contrast, neuregulin stimulates
lobulo-alveolar differentiation and the production of milk
proteins. Thus, different growth factors elicit distinct re-
sponses in organ culture of the mammary gland. This find-
ing raises the question whether different cellular popu-
lations react to these factors, and how these different
responses are evoked on a molecular level.
In collagen matrix, HGF/SF induces the formation of
branched tubules from epithelial cells derived from the
kidney (MDCK), mammary gland, and other organs
(Montesano et al., 1991
 
a
 
,
 
b
 
; Berdichevsky et al., 1994;
Brinkmann et al., 1995; Soriano et al., 1995). HGF/SF sig-
nals are mediated by the receptor tyrosine kinase c-met; in
vivo
 
,
 
 c-met is expressed by various epithelial cells, whereas
HGF/SF transcripts are found in the mesenchymal com-
partment (Bottaro et al., 1991; Naldini et al., 1991; Son-
nenberg et al., 1993; Weidner et al., 1993). The phosphory-
lated c-met receptor binds substrates such as PI3K, PLC-
 
g
 
,
Grb2, and others (Ponzetto et al., 1994; Fixman et al.,
1997). A recently identified c-met-specific substrate, Gab1
(Weidner et al., 1996; Nguyen et al., 1997) suffices to elicit
branching morphogenesis in kidney epithelial cells.
Neuregulin has been shown to affect growth and differ-
entiation of epithelial and other cell types in vitro
 
 
 
(Peles
et al., 1992; Bacus et al., 1993; Falls et al., 1993; Marchi-
onni et al., 1993; Shah et al., 1994; Staebler et al., 1994;
Marte et al., 1995). Neuregulin signals are mediated by di-
rect interaction with the high affinity receptors c-erbB4 or
c-erbB3; in addition, c-erbB2 acts as an essential corecep-
tor for the transmission of neuregulin signals (Plowman et
al. 1993; Carraway and Cantley, 1994; Carraway et al.,
1994; Sliwkowski et al., 1994). Neuregulin is expressed in
neuronal and mesenchymal cells during mouse develop-
ment (Orr-Urtreger et al., 1993; Meyer and Birchmeier,
1994; Yang et al., 1995), whereas the receptors are found
in epithelial and other cell types (Kraus et al., 1989; Press
et al., 1990; Prigent et al., 1992; Plowman et al., 1993;
Meyer et al., 1997).
Previously, analyses of HGF/SF and neuregulin-evoked
responses in epithelial cells were mainly conducted with
cells grown in monolayers; such culture conditions do not
allow the formation of the complex three-dimensional
structures observed during organ development. In con-
trast, organ culture systems provide a good model for the
analysis of morphogenic events. However, they preclude a
biochemical analysis of signaling cascades activated by
morphogenic factors due to their complex cellular compo-
sition. Obviously, a lack of appropriate systems exists
which allows the study of signaling cascades responsible
for morphogenic responses, for instance in mammary epi-
thelial cells.
Here we use EpH4 mammary epithelial cells grown on
matrigel and observe that two growth factors that signal
via tyrosine kinase receptors, HGF/SF and neuregulin,
elicit fundamentally distinct morphogenic responses in
these pluripotent cells: HGF/SF induces the formation of
branched tubules, and neuregulin evokes the formation of
alveolar structures. The complex structures generated in
culture resembles the ones formed during mammary gland
development. The HGF/SF-induced tubular structures
were also observed after transfection of a c-met substrate,
Gab1. The alveolar structures produced by neuregulin
could also be induced by nerve growth factor in cells trans-
fected with a trk/c-erbB2 hybrid receptor; this indicates
that the signals provided by c-erbB2 suffice to induce alve-
oli. By the use of mutant receptors and specific inhibitors,
we could show that PI3 kinase provides an essential signal
for branching morphogenesis; in contrast, the MAP kinase
pathway plays an essential role for the formation of alveo-
lar structures. Thus, in this cell culture system one single
cell type, EpH4, responds by two entirely different mor-
phogenic programs upon stimulation of distinct tyrosine
kinase receptors. The distinct responses can moreover be
correlated with the activation of different essential signal-
ing cascades.
 
Materials and Methods
 
Recombinant HGF/SF and Neuregulin
 
Recombinant HGF/SF was produced in Sf9 insect cells using the baculovi-
rus expression system as described (Weidner et al., 1993; Brinkmann et
al., 1995). For production of neuregulin, the coding sequence (correspond-
ing to amino acids 20–239) of a mouse 
 
b
 
2
 
 isoform (Wen et al., 1992; Meyer
and Birchmeier, 1994) was fused in frame to the signal sequence of the
baculovirus expression vector pAcGP67 (Dianova, Hamburg, Germany)
followed by bulk transfection of Sf21 insect cells using calcium phosphate.
Recombinant baculovirus was selected by plaque screening and biological
assay, and high-titer virus was used to infect Sf21 cells in serum-free Ex-
cell 401 medium (Seralab, Crowley Down, UK) supplemented with 0.1%
Pluronic F-68 (Life Technologies, Gaithersburg, MD). Conditioned me-
dium was clarified after 3 d of culture, and neuregulin was purified on a
heparin–Sepharose column (Pharmacia, Uppsala, Sweden) by the elution
by a 0.4–1.2-M NaCl gradient. The fractions were tested for biological ac-
tivity of neuregulin in the morphology assay on MDA MB 453 cells (Plow-
man et al., 1993) and for protein on a silver-stained gel. Neuregulin with
highest biological activity eluted at 0.8–1.0 M NaCl.
 
Cell Culture on Matrigel
 
EpH4 cells are a derivative of IM-2 and were originally isolated from
mammary tissue of a mid-pregnant mouse (Reichmann et al., 1989; Brink-
mann et al., 1995; Lopez-Barahona et al., 1995). From EpH4 cells we sub-
cloned the variant K6 (called EpH4/K6) which exhibits a pronounced
morphogenic potential on matrigel.
Matrigel (basement membrane from Engelbreth-Holm-Swarm tumor)
was obtained from Collaborative Biomedical Products (Serva, Germany),
and 6-cm culture dishes were coated with 400 
 
m
 
l of this solution on ice. Af-
ter incubation for 1 h at 37
 
8
 
C to allow the matrix to gel, 3.5 
 
3 
 
10
 
5
 
 EpH4
cells were plated in DME containing 10% fetal bovine serum and the fol-
lowing hormones: 3 
 
m
 
g/ml bovine prolactin (Sigma Chemical Co., St.
Louis, MO); 5 
 
m
 
g/ml insulin (Sigma Chemical Co.); 1 
 
m
 
g/ml hydrocorti-
sone (Merck, Darmstadt, Germany), and neuregulin or HGF/SF at con-
centrations of 20 ng/ml (100 U/ml) or 3 nM (1 U/ml), respectively. After
1 d of culture, medium was replaced by serum-free DME containing fac-
tors and hormones and exchanged daily. Experiments were terminated af-
ter 6 d of culture. Inhibitors of the PI3 kinase (10 nM wortmannin and
25 
 
m
 
M LY294002) and MAPK kinase (50 
 
m
 
m PD98059) were added twice
a day and experiments were terminated after 3 d of culture (Alessi et al.,
1995; Derman et al., 1995; Keely et al., 1997; Khwaja et al., 1997).
 
Transfection of EpH4 Cells with cDNAs
 
Hybrid receptors containing the extracellular portion of trk (the nerve
growth factor receptor) and the transmembrane and cytoplasmic region of
epithelial receptor tyrosine kinases (trk/c-met, trk/KGFR, and trk/c-erbB2)
have been described (Sachs et al. 1996). cDNA encoding a new hybrid re-
ceptor containing the cytoplasmic domain of c-erbB4, trk/c-erbB4, was 
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constructed. Mutations were introduced into the kinase domain of trk/
c-erbB2 by an exchange of wild-type and mutant c-erbB2 sequences (Ben-
Levy et al., 1994): trk/c-erbB2-P1 lacks all COOH-terminal substrate-
binding domain of c-erbB2 but the sequences around the ultimate tyrosine
residue, Y1253, which is directly fused to the c-erbB2 kinase domain; trk/
c-erbB2Y1253F contains the complete substrate-binding region except the
fifth tyrosine residue, which is mutated to phenylalanine (Y1253F). The
cDNAs of these hybrid receptors and of Gab1 (Weidner et al., 1996) were
cloned into the pBAT expression vector; the expression plasmids were
cotransfected with pSV2neo into EpH4/K6 mammary epithelial cells by
the calcium phosphate technique. Cell clones producing the trk-hybrid re-
ceptors were identified (Sachs et al., 1996) and characterized for their
morphogenic response on matrigel after addition of nerve growth factor
(NGF). Control transfections were performed with pSV2neo only.
 
Explant Cultures of Human Mammary Tumors
 
Human breast tumors cultivated as xenografts in the mammary glands of
nude mice (Naundorf et al., 1992) were dissected and cut into 1-mm pieces
in medium 199 (GIBCO BRL, Eggenstein, Germany) supplemented with
5 
 
m
 
g/ml insulin and recombinant HGF/SF or neuregulin at a concentration
of 20 ng/ml (100 U/ml) and 3 nM (1 U/ml), respectively. The tissue pieces
were placed into 25 cm
 
2
 
 Falcon plastic flasks at a density of 30 explants per
flask (Falcon Plastics, Cockeysville, MD). The explants were cultured for
8 d under an atmosphere of 5% CO
 
2
 
, with daily medium changes (Binas et
al., 1992). For histological analysis, explants were fixed in 4% formalin,
embedded in paraffin, sectioned (5 
 
m
 
m), and then stained with hematoxy-
lin/eosin (Rivera, 1971).
 
Northern Hybridization
 
Total RNA was isolated from dispase-treated EpH4 cell aggregates as de-
scribed (Chomczynski and Sacchi, 1987). 5–20 
 
m
 
g RNA were electro-
phoresed in 1% agarose–formaldehyde gels and transferred to Hybond-
C-extra membranes (Amersham, Little Chalfont, UK) and hybridized to
 
32
 
P-labeled cDNA probes for 
 
b
 
-casein (Binas et al., 1992) and 
 
b
 
-actin, re-
spectively. The probes were labeled by random priming (10
 
9 
 
cpm/
 
m
 
g;
Feinberg and Vogelstein, 1984). Hybridization signals were autoradio-
graphed and analyzed with a phosphoimager.
 
Light, Confocal, and Electron Microscopy
 
Cell aggregates of EpH4 cells after 6 d of culture were visualized using a
Zeiss Axiovert 135 inverse microscope equipped with Nomarski optics
(Carl Zeiss Inc., Thornwood, NY). For histological examination, orga-
noids were fixed in situ with 2.5% glutaraldehyde, postfixed with OsO
 
4
 
,
and contrasted with tannic acid and uranyl acetate. Specimens were dehy-
drated in a graded ethanol series and embedded in Epon 812. For light mi-
croscopy, semithin sections (0.5 
 
m
 
m) were stained with toluidin blue and
analyzed in a Zeiss Axiophot light microscope. Ultrathin sections (50–70
nm) were contrasted with lead citrate and analyzed in a Zeiss EM 10 elec-
tron microscope.
For immunohistological analysis, organoids were fixed with 4% formal-
dehyde in PBS and treated with 0.5% Triton X-100. Antibodies used were
monoclonal rat anti–E-cadherin (DECMA-1, Vestweber and Kemler,
1985), rabbit anti–
 
b
 
-casein (Binas et al., 1992), CY3-conjugated goat anti–
Figure 1. Effect of HGF/SF on the morphology of EpH4/K6 mammary epithelial cells on matrigel. Cells were cultured in medium con-
taining hormones in the absence (a and d) or in the presence of HGF/SF (b and e). Small aggregates with (arrow) or without lumen were
formed in the absence of factor. HGF/SF induced branching tubules with prominent lumina (arrows in b) and end buds (arrowheads in
b). Gab1-transfected EpH4/K6 cells exhibited a similar morphogenic response in the absence of HGF/SF (c and f). Top, micrographs us-
ing Nomarski optics; bottom, semithin sections of Epon-embedded cultures. Bars: (a) 50 mm; (c) 25 mm. 
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rat and CY5-conjugated goat anti–rabbit antibodies. Nuclei were stained
with quinacrine mustard or Sytox (Molecular Probes, Eugene, OR). The
whole mounts were analyzed using a Leica TCS confocal microscope
(Leica, St. Gallen, Switzerland).
 
Results
 
Effect of HGF/SF on Morphogenesis and Functional 
Differentiation of EpH4 Mammary Epithelial Cells
 
EpH4/K6 mouse mammary epithelial cells (Reichmann et
al., 1989; refer to Materials and Methods) cultured on
matrigel in the presence of hormones grow slowly, form
small spheroids and secrete milk proteins. Lumina in these
structures are surrounded by a single layer of epithelial
cells (Fig. 1 
 
a
 
). This resembles the appearance of primary
or CID9 mammary epithelial cells grown in matrigel (Bis-
sell and Ram, 1989; Wicha et al., 1982; Wilde et al., 1984;
Hahm and Ip, 1990
 
a
 
,
 
b
 
; Schmidhauser et al., 1992). When
HGF/SF was added to the EpH4/K6 cell cultures, fast
growing, long tubular structures that can reach a length of
several millimeters were observed (Fig. 1 
 
b
 
). 44% of the
HGF/SF-induced aggregates were tubular, of which 26%
were branched (two to seven branches per structure, Fig. 2
 
B
 
). In control cultures, 90% of the aggregates were small
and round, and only 3% showed an elongated structure
(Fig. 2 
 
A
 
). The K6 subline of EpH4 cells produces particu-
larly pronounced tubular structures in the presence of
HGF/SF; however, these structures were also observed
with the original EpH4 cells, albeit at lower frequency. 20
ng/ml of HGF/SF produced an optimal morphogenic re-
sponse of EpH4/K6 cells. Histological analysis confirmed
that in the absence of HGF/SF, EpH4/K6 cells form loose
aggregates or small spheroids, and that the lumina are
lined by a layer of flattened cells (Fig. 1 
 
d
 
; see also below).
The tubular structures induced by HGF/SF consist of sev-
eral layers of cuboidal cells lining the elongated lumina
(Fig. 1 
 
e
 
). We also tested other growth factors: epidermal
growth factor (EGF) stimulated growth but did not induce
branched tubules, whereas keratinocyte growth factor
(KGF) had a moderate effect on growth but did not elicit
morphogenic responses.
EpH4/K6 cells were transfected with the cDNA of the
recently identified new substrate of c-met, Gab1 (Weidner
et al., 1996; refer to Materials and Methods). When grown
in matrigel, the transfected cells produced tubular and
branched structures, now in the absence of HGF/SF (Fig. 1
 
c
 
). This was not observed with cells transfected with con-
trol plasmids (pSV2neo). The histology of the Gab-1–
induced structures was identical to those observed in the
presence of HGF/SF (Fig. 1 
 
f
 
). Branched tubular struc-
tures could also be produced in EpH4/K6 cells transfected
 
Figure 2.
 
Statistical analysis of the effects of HGF/SF (
 
B
 
) and
neuregulin (
 
C
 
) on the morphology of EpH4/K6 cells on matrigel.
Control aggregates in the absence of the factors are analyzed in
 
A
 
. From three sets of experiments, a total of 1,050 structures
were examined. The different groups of structures are indicated
in the box, i.e., small aggregates without or with lumen (smaller
than 50 
 
m
 
m), elongated tubes, and round large alveoli (larger
than 50 
 
m
 
m). 
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with a trk/c-met receptor hybrid (Sachs et al., 1996) when
the cells were stimulated by NGF (data not shown). EpH4/
K6 cells transfected with trk/KGFR or trk did not produce
branched tubules in the presence of NGF. Together, these
data demonstrate that the formation of branching struc-
tures of EpH4 cells requires specific signals provided by
the c-met receptor tyrosine kinase.
The effect of HGF/SF on the expression of 
 
b
 
-casein dur-
ing formation of tubules was analyzed by Northern blot
hybridization (Fig. 3). HGF/SF strongly inhibited 
 
b
 
-casein
mRNA expression in a concentration-dependent fashion;
inhibition was maximal at 20 ng/ml HGF/SF (Fig. 3 
 
C
 
).
Apparently, formation of branching tubules of EpH4
mammary epithelial cells does not allow concomitant
functional differentiation.
 
Effect of Neuregulin on the Morphogenesis of EpH4 
Mammary Epithelial Cells
 
Neuregulin produces an entirely different response in
EpH4/K6 cells: fast growing, large alveolar-like structures
are formed (Fig. 4 
 
a
 
, compare with the small aggregates in
the control in Fig. 1 
 
a
 
). The concentration of 3 nM of neu-
regulin was more effective than higher or lower concentra-
tions. Histological analysis demonstrated that the alveoli
consisted of single-layered, highly columnar epithelial cells
(Fig. 4 
 
c
 
, see also below). Statistical analysis revealed that
75% of the structures had an alveolar-like morphology
and contained a lumen (Fig. 2 
 
c
 
): the aggregates were gen-
erally larger than 100 
 
m
 
m, and 15% were larger than 200
 
m
 
m. The original EpH4 cells produced the same struc-
tures, but at lower frequencies. In contrast, only 5% of the
aggregates formed by cells grown in the absence of neu-
regulin exhibited large alveolar structures (Fig. 2 
 
A
 
).
Other growth factors tested, like EGF or KGF, did not in-
duce alveolar structures (data not shown).
EpH4/K6 cells were then transfected with the cDNAs of
receptor hybrids consisting of extracellular trk (the NGF
receptor) and intracellular c-erbBs (Sachs et al., 1996; see
also Materials and Methods). Remarkably, stable clones
of EpH4/K6 mammary epithelial cells which expressed the
hybrid trk/c-erbB2 receptor produced alveolar-like struc-
tures in the presence of NGF (Fig. 4 
 
b
 
, see also the statis-
tics in Fig. 5 
 
A
 
). These structures were histologically iden-
tical to the neuregulin-induced structures of EpH4/K6
cells (Fig. 4 
 
d
 
). Control transfectants with pSV2neo, trk, or
a trk/KGFR hybrid (Sachs et al., 1996) did not show a
morphogenic response in matrigel (data not shown). Simi-
larly, stable cell clones expressing a trk/c-erbB4 hybrid re-
ceptor did not form alveolar structures in response to
NGF, although NGF-dependent tyrosine phosphorylation
of the receptor was observed (data not shown). We then
Figure 3. Effect of HGF/SF
on the expression of b-casein
in EpH4 mammary epithelial
cells cultured on matrigel in
the presence of lactogenic
hormones. (A) Representa-
tive autoradiograph of a
Northern blot showing the
inhibition of b-casein expres-
sion by HGF/SF after 6 d of
culture (lane b); control in
the absence of HGF/SF (lane
a). RNA from mammary
glands of a pregnant mouse
served as a control for b-casein
expression (lane c). (B) Time course of expression of b-casein in EpH4 cells over 6 d of culture in the absence (s) or presence of HGF/
SF (d), as analyzed by Northern blotting. Radioactive counts are expressed using a phosphoimager. (C) Concentration dependence on
HGF/SF of the inhibition of b-casein expression. Control in the absence of HGF/SF was set to 100%.
Figure 4. Effect of neuregulin on morphogenesis of mammary
epithelial cells EpH4/K6 on matrigel. Cells were cultured for 6 d
in medium containing hormones in the presence of neuregulin (a
and c; for the control in the absence of neuregulin refer to Fig. 1
a). Large alveolar structures were formed which were predomi-
nantly built up by a single layer of columnar epithelial cells. Iden-
tical structures were observed in EpH4/K6 cells transfected with
a trk/c-erbB2 hybrid receptor and stimulated with NGF (b and
d). Top, micrograph using Nomarski optics; bottom, semithin sec-
tions of Epon-embedded cultures. Bars: (b) 50 mm; (d) 25 mm.The Journal of Cell Biology, Volume 143, 1998 538
sults suggest that the formation of tubular structures by
HGF/SF/c-met requires pathways involving PI3 kinase,
whereas alveoli formation depends on the activity of MAP
kinase pathways.
The effects of HGF/SF and neuregulin seen on matrigel
reveal striking similarities to the results obtained in whole
organ culture (Yang et al., 1995). Since HGF/SF and neu-
regulin are expressed sequentially during mammary gland
development, we also added the factors in a consecutive
manner to EpH4 cells. We thus cultured the cells on matri-
gel for 4 d first in the presence of HGF/SF, removed HGF/
SF and cultured the cells in the presence of neuregulin for
an additional 4 d. Complex structures were formed con-
sisting of branched tubules with adherent alveoli along the
tubes and at branching points (data not shown). In these
sequential experiments, expression of b-casein was exam-
ined: HGF/SF inhibited b-casein expression in the first
phase; removal of HGF/SF allowed re-expression of
b-casein (Fig. 7, A and B). Addition of neuregulin in-
creased  b-casein expression slightly compared with control
levels.
Differential Effects of HGF/SF and Neuregulin on
the Polarity of EpH4 Cells and on Expression of Cell 
Adhesion Molecules
The ultrastructure of the HGF/SF and neuregulin-induced
aggregates was examined, and the distribution of the cell
adhesion molecule E-cadherin and the expression of the
differentiation marker b-casein were visualized by immu-
nofluorescence analysis. In the control aggregates, cells that
surround lumina contain flat nuclei and many vesicles with
electron-dense material, likely representing casein-con-
taining vesicles (Fig. 8 a). Immunofluorescence analysis
revealed that b-casein expression was high in the controls;
E-cadherin was evenly distributed along all cell surfaces,
suggesting only moderate polarization of the cells (Fig. 9, a
and arrows in d);. The HGF/SF-induced tubular structures
were composed of more cuboidal cells with round nuclei
(Fig. 8 b). b-Casein production was reduced by HGF/SF,
as assessed by the reduction in numbers of vesicles and by
the reduction of immunofluorescence-staining intensity
(Fig. 8 b and Fig. 9, b and e). E-cadherin was largely dis-
tributed along the whole cell surface (Fig. 9 b, arrows in e).
However, the cells in neuregulin-induced alveoli showed
higher degree of polarization, as revealed by the columnar
cell shape and the elongation of nuclei along the apical–
basal axis (Fig. 8 c). E-cadherin was now predominantly
located at lateral membranes, in accordance with the more
pronounced polarization of the cells (Fig. 9, c and arrows
in f). b-Casein was strongly expressed, as assessed by the
increased numbers of vesicles and the staining intensity
observed by immunofluorescence analysis (Fig. 8 c  and
Fig. 9, c and f).
Morphogenesis Responses to HGF/SF and Neuregulin 
on Explants of Human Breast Carcinoma Cells
To analyze whether the different morphogenic responses
are restricted to EpH4 cells, we examined morphogenic
responses in explant culture of human breast carcinomas
obtained as xenografts. Xenografts of estrogen-responsive
and -nonresponsive tumors were dissected into 1 3 1-mm
Figure 5. Statistical analysis
of NGF-induced morpholog-
ical responses of EpH4/K6
cells transfected with the hy-
brid receptors trk/c-erbB2
(A), trk/c-erbB2-P1 (B) or
trk/c-erbB2Y1253F (C). For
each set of experiments, a to-
tal of 450 structures from
each of four different stably
expressing clones were ana-
lyzed. The aggregates are de-
fined as in Fig. 2 (inset).
examined EpH4/K6 cells expressing mutants of trk/c-erbB2
to identify essential docking sites in the erbB2 receptor
that elicit this morphogenic response: a mutant of c-erbB2
that contains only the ultimate tyrosine residue P1 (Y1253;
Ben-Levy et al., 1994) was inactive (Fig. 5 B), whereas a
mutant containing the residual tyrosine residues (Y1028,
Y1144, Y1201, and Y1226/27) produced alveoli (Fig. 5 C).
This indicates that tyrosine residue Y1028, Y1144, Y1201,
and Y1226/27 of c-erbB2, but not Y1253, are important for
mediating the neuregulin-induced morphogenic response.
Moreover, these findings demonstrate that an activated
trk/erbB2 receptor is capable of eliciting a specific mor-
phogenic response in mammary epithelial cells, formation
of alveolar-like structures, in the absence of active c-erbB3
and c-erbB4 coreceptors.
Effect of Inhibitors of PI3 Kinase and MAPK
Kinase on the Formation of Morphogenic Structures
of EpH4 Cells
Addition of wortmannin and LY294002 to EpH4/K6 cells
significantly reduced the production of tubular structures
by HGF/SF, whereas PD9805 was without effect (Fig. 6).
In contrast, PD98059 quenched the induction of large al-
veoli, whereas wortmannin was without effect. These re-Niemann et al. HGF and Neuregulin in Mammary Gland Morphogenesis 539
pieces and cultured in the presence or absence of HGF/SF
or neuregulin (refer to Materials and Methods for details).
In the absence of factors, the explants from estrogen-
dependent tumor 3366 (which was grown at minimal estro-
gen concentration in nude mice; Naundorf et al., 1992)
were mainly composed of stromal tissue containing scat-
tered epithelial islands that showed little mammary gland-
specific differentiation (Fig. 10, a and b and Fig. 11, a–c).
In the presence of HGF/SF, epithelial proliferation was
strongly promoted and epithelial cells formed multilay-
ered, cribiform, and papillary structures (Fig. 10, c and d
and c9 and d9). Duct-like structures were also observed.
Thus, a similar multicellular organization was observed in
HGF/SF-treated tumor tissue as in EpH4 cells grown on
matrigel. No morphogenic response to HGF/SF was ob-
served in the estrogen-independent human breast carci-
noma 4151 (data not shown) (Naundorf et al., 1993). In
contrast, addition of neuregulin to explants of the estro-
gen-responsive tumor 3366 produced an entirely different
response: growth of epithelial cells was moderately pro-
moted, epithelial sheets were predominantly single layered
and cells lining the newly formed lumina were well polar-
ized (Fig. 11, d–f), Thus, tumor explants and EpH4 cells on
matrigel both form alveoli-like structures when exposed to
neuregulin. No morphological response of tumor 4151 was
detected in response to neuregulin (data not shown).
Discussion
We show here that EpH4 mammary gland epithelial cells
on matrigel respond in distinct manners when stimulated
with HGF/SF or neuregulin. HGF/SF induces branched
multilayered tubes and inhibits the production of milk
proteins. In contrast, neuregulin induces alveolar-like ag-
Figure 6. Effects of inhibitors of the PI3 kinase
(wortmannin and LY294002) and MAPK kinase
(PD98059) on the formation of elongated struc-
tures (A) and the formation of round, large alve-
oli (B). Experiments were terminated after 3 d of
culture. From two sets of experiments, 350 cell
aggregates each were analyzed.
Figure 7. Effect of HGF/SF
and neuregulin on the ex-
pression of b-casein in mam-
mary epithelial cells EpH4
after their sequential applica-
tion. (A) A representative
Northern blot. (B) Quantifi-
cation of Northern blot by
phosphoimager analysis. Ra-
dioactive counts are ex-
pressed as PSL. Cells were
cultured in medium contain-
ing hormones for 4 d in the
presence of HGF/SF (lane
b) and for an additional 4 d
in the absence (lane f) or
presence of HGF/SF (lane e)
or neuregulin (lane d). Con-
trol cells were cultured in
medium containing hor-
mones without addition of
factors (lanes a and c). Inset
in B indicates the respective
culture conditions.The Journal of Cell Biology, Volume 143, 1998 540
gregates which often consist of a monolayered epithelium,
and allows b-casein expression. HGF/SF and neuregulin
can thus induce complex morphogenic programs in mam-
mary gland epithelial cells, which are also observed in the
mammary gland during postnatal development. We used
this cell culture system for the biochemical analysis of sig-
nals elicited by HGF/SF and neuregulin: the formation of
branched tubules was found to be dependent on c-met and
a pathway involving Gab1 and PI3 kinase, whereas alveo-
lar formation required c-erbB2 and components of the ras/
MAPK kinase pathway.
Morphogenic activities of various factors on mammary
gland development have been examined; for instance,
EGF (or TGF-a) and TGF-b influence ductal and alveolar
development (Silberstein and Daniel, 1987; Vonderhaar,
1987; Coleman et al., 1988; Jhappan et al., 1990, 1993;
Robinson et al., 1991; Snedeker et al., 1991; Daniel and
Robinson, 1992; Pierce et al., 1993); these factors are pre-
dominantly produced in an autocrine fashion by epithelial
cells and are expressed throughout mammary gland devel-
opment. Since mesenchymal–epithelial interactions are es-
sential for pre- and postnatal development of the mam-
mary gland (Kratochwil, 1976, 1987; Sakakura et al., 1976,
1991; Durnberger et al., 1980; Cunha et al., 1992; Cunha
and Hom, 1996), we have focused on the functional analy-
sis of mesenchymal ligands (HGF/SF and neuregulin) and
epithelial tyrosine kinase receptors (c-met and c-erbBs) in
this process. In vivo, HGF/SF and neuregulin are ex-
pressed specifically during puberty and pregnancy in the
mesenchyme of the mammary gland, and promote branch-
ing and lobulo-alveolar morphogenesis in whole organ cul-
ture, respectively (Yang et al., 1995). The HGF/SF recep-
tor c-met and the neuregulin receptors (erbB2, erbB3, and
erbB4) are produced in the outer epithelial cells of the
ducts (Yang et al., 1995). Here we show that HGF/SF in-
duces growth and morphogenesis of EpH4 mammary epi-
thelial cells in matrigel; long multilayered tubes are
formed from loose aggregates or small spheroids. Interest-
ingly, HGF/SF inhibits the expression of b-casein, indicat-
ing that a morphogenic program without concomitant
functional differentiation is activated. This is consistent
with processes that are observed in vivo: milk production
is blocked during tubular branching. HGF/SF-induced tu-
bule formation and branching of mammary gland cells was
also previously reported in collagen matrix (Berdichevsky
et al., 1994; Brinkmann et al., 1995; Soriano et al., 1995);
concomitant inhibition of functional differentiation had
not been observed and might be a specific response to the
specific substrate used here, i.e., matrigel. Neuregulin ex-
erts an entirely different response of EpH4 mammary epi-
thelial cells in matrigel: alveolar-like structures are in-
duced which consist of single-layered epithelia. Thus, we
assign here a morphogenic role to neuregulin in mammary
epithelial cells; such a function is in accordance with previ-
ous whole organ culture experiments (Yang et al., 1995).
Our data thus show that signaling of two different tyrosine
kinase receptor types, c-met and c-erbB, elicits distinct
morphogenic responses in a single mammary gland epithe-
lial cell line. In whole organ cultures (Yang et al., 1995),
HGF/SF and neuregulin stimulated preexisting structures,
i.e., the factors enhanced either tubular or alveolar mor-
phogenesis. Here we show that HGF/SF and neuregulin
can induce these two morphogenic programs from cell ag-
gregates that are apparently pluripotent.
Epithelial cells derived from the kidney, breast and
other organs respond to SF/HGF and c-met by the forma-
tion of branched tubules when grown in a collagen matrix
(Montesano et al., 1991a,b; Weidner et al., 1993; Ber-
dichevsky et al., 1994; Soriano et al., 1995; Brinkmann et
al., 1995). Furthermore, several tyrosine kinase receptors
were reported to affect epithelial cells (e.g., trk, c-ros, the
KGF-R) but only c-met induces tubulogenesis (Sachs et
al., 1996). Although a variety of substrates were found to
bind to the tyrosine phosphorylation sites in the COOH
terminus of c-met (Ponzetto et al., 1994; Fixman et al.,
1995; Weidner et al., 1995), a substrate which can mediate
the signal responsible for branching morphogenesis, Gab1,
has only recently been identified (Weidner et al., 1996).
Gab1 binds specifically to c-met but not to various other
receptor tyrosine kinases. We show here that Gab1 also
promotes the formation of branched tubules from EpH4
mammary epithelial cells. Thus, Gab1 is an important sub-
strate that transduces this morphogenic signal in various
epithelial cell types. In a recent report it was shown that
Figure 8. Ultrastructural
analysis of EpH4/K6 cells
grown under control condi-
tions (a) and in the presence
of HGF/SF (b) or neuregulin
(c). Control aggregates often
had small lumina lined by
flattened cells containing
numerous electron-dense
granules (arrows). HGF/SF-
induced tubules were lined
by cuboidal cells with round
nuclei and contained a re-
duced number of secretory
granules. Neuregulin-induced
alveoli had columnar epithe-
lial cells with nuclei often
elongated along the apical–basal axis and with abundant secretory vesicles. The lumina in most of neuregulin-treated structures were
spacious; for better demonstrability, a small alveolus was selected here.Niemann et al. HGF and Neuregulin in Mammary Gland Morphogenesis 541
Stat 3 is also required for the formation of branching struc-
tures (Boccaccio et al., 1998). The production of milk con-
stituents in the mammary gland is under tight hormonal
control and influenced by extracellular matrix compo-
nents. Stat 5 is an essential factor for the prolactin-con-
trolled b-casein gene expression (Happ and Groner, 1993;
Schmidhauser et al., 1992; Sympson et al., 1994; Groner et
al., 1994; Wakao et al., 1995; Streuli et al., 1995). c-met sig-
naling might thus interfere with the activity of Stat 5.
Neuregulin signaling requires the c-erbB3 or c-erbB4
receptors, which bind neuregulin with high affinity, and
c-erbB2, that acts as an essential coreceptor (Kita et al.,
1994; Carraway et al., 1994; Tzahar et al., 1994; Carraway
and Burden, 1995; Marikovsky et al., 1995; Karunagaran et
al., 1995; Meyer and Birchmeier, 1995; Lee et al., 1995;
Gassmann et al., 1995; Riese et al., 1995; Pinkas-Kramar-
ski et al., 1996; Riethmacher et al., 1997). The c-erbB2 re-
ceptor binds substrates like Shc (Segatto et al., 1993),
Grb2 (D’souza and Taylor-Papadimitriou, 1994), PLC-g
(Songyang et al., 1993; Ben-Levy et al., 1994), and Grb7
(Stein et al., 1994). It has recently been shown that of the
phosphorylated tyrosine residues found in the COOH-
terminal substrate-binding domain of c-erbB2, tyrosine
Y1144 (tyrosine 2) binds Grb2, and Y1227 (tyrosine 4)
binds Shc (Dankort et al., 1997); both substrates signal
through the ras pathway. The signaling capacities of Y
1201 (tyrosine 3) and Y1253 (tyrosine 5) are unknown. Ty-
rosines 1–4 were found to be necessary for the mitogenic
response of c-erbB2 (Dankort et al., 1997); others ob-
served that tyrosine residue 5 was required for this activity
(Ben-Levy et al., 1994). By the use of a trk/c-erbB2 hybrid
receptor, we demonstrate here that c-erbB2 induces alve-
olar-like differentiation in mammary epithelial cells with-
out activation of coreceptors. Furthermore, a hybrid re-
ceptor of c-erbB2 containing tyrosines 1–4 is sufficient to
induce alveolar structures; a hybrid containing only ty-
rosine 5 is not.
We have examined inhibitors that specifically interfere
Figure 9. Scanning confocal micrograph of EpH4/K6 aggregates treated with HGF/SF (b and e) or neuregulin (c and f); controls are
shown in a and d. Green, nuclei; red, E-cadherin; blue, b-casein. In control- and HGF/SF-treated cultures, E-cadherin is evenly distrib-
uted along all cell surfaces (arrows in d and e). Neuregulin-treated cells exhibit a stronger polarity resulting in a predominantly lateral
localization of E-cadherin. b-Casein expression is strongly inhibited in HGF/SF-treated cells.The Journal of Cell Biology, Volume 143, 1998 542
with signaling pathways activated by HGF/SF and neureg-
ulin to analyze their effect on the morphogenic response
evoked by these factors. The c-met receptor can poten-
tially signal through ras and PI3 kinase (Hartmann et al.,
1994; Ponzetto et al., 1994; Royal and Park, 1995; Royal et
al., 1997). Signaling through ras and the resulting cellular
growth require the substrate Grb2, which binds to tyrosine
residue Y1354 of c-met (i.e., the second tyrosine residue of
the bidentate docking site) (Ponzetto et al., 1994; Fixman
et al., 1995; Nguyen et al., 1997). Motility and morpho-
genic responses evoked by c-met require the substrate
Gab1, which binds strongly to Y1347 (the first residue of
the bidentate docking site; Weidner et al., 1996; Nguyen et
al., 1997). Gab1 can also bind to Y1354, but in the pres-
ence of Grb2 binding to Y1347 is preferred and stabilized
(Nguyen et al., 1997). Furthermore, Gab1-binding blocks
the SH3 domain of Grb2 (Holgado-Madruga et al., 1996),
and Gab1 harbors three PI3 kinase-binding sites. Indeed,
we find that inhibitors of PI3 kinase (wortmannin and
LY294002) specifically reduce HGF/SF-induced forma-
tion of tubules. This suggests that branching morphogene-
sis depends on the activity of pathways requiring PI3 ki-
nase. In contrast, alveolar morphogenesis of EpH4 cells by
c-erbB2 could be blocked by inhibitors of MAPK kinase,
i.e., PD98059. Thus, components of the ras/MAP kinase
pathways play an essential role in alveolar morphogenesis.
It will now be important to identify which substrates (or
substrate combinations) elicit the alveolar morphogenesis
that is induced by the c-erbB2 receptor.
The morphogenic activities of HGF/SF and neuregulin
can be used to reconstitute further steps of postnatal mam-
mary gland development in vitro. In the matrigel system
established here, interactions of morphogenic factors with
other mediators of growth and differentiation such as hor-
mones, extracellular matrix components, or other mesen-
chymal factors can be studied in the future. Furthermore,
downstream signaling processes that elicit the different
morphogenic programs and eventually result in changes in
gene expression are now amenable to investigation.
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